Artificial Intelligence‐Based Assessment With Line‐Field Confocal Optical Coherence Tomography ( LC ‐ OCT ) During Topical Ruxolitinib Therapy for Vitiligo
International Journal of Dermatology · 05.08.2026
DOI: 10.1111/ijd.70614 ↗Kurz gefasst
Leserbrief in der Zeitschrift International Journal of Dermatology, online erschienen am 05.08.2026. Verfasst von Alessia Paganelli und 5 weiteren Autor:innen. Beteiligte Einrichtung: IDI-IRCCS Dermatological Research Hospital, Rome, Italy. Die Arbeit nennt 5 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- IDI-IRCCS Dermatological Research Hospital, Rome, Italy.
- Department of Life Science, Health and Health Professions, Link University of Rome, Rome, Italy.
- UniCamillus, Saint Camillus International University, Rome, Italy.
- Dermatology Unit, Department of Medical and Cardiovascular Sciences, Sapienza University of Rome, Rome, Italy.
- Dermatology Clinic, Maggiore Hospital of Trieste, Trieste, Italy.
ORCID-Profile: Alessia Paganelli, Luca Ambrosio, Iris Zalaudek, Claudio Conforti
Zitieren
APA
Paganelli, A., Picardo, M., Ambrosio, L., Zalaudek, I., Pellacani, G., & Conforti, C. (2026). Artificial Intelligence‐Based Assessment With Line‐Field Confocal Optical Coherence Tomography ( LC ‐ OCT ) During Topical Ruxolitinib Therapy for Vitiligo. International Journal of Dermatology. https://doi.org/10.1111/ijd.70614
Vancouver
Paganelli A, Picardo M, Ambrosio L, Zalaudek I, Pellacani G, Conforti C. Artificial Intelligence‐Based Assessment With Line‐Field Confocal Optical Coherence Tomography ( LC ‐ OCT ) During Topical Ruxolitinib Therapy for Vitiligo. International Journal of Dermatology. 2026. doi:10.1111/ijd.70614
BibTeX
@article{Paganelli2026,
author = {Paganelli, Alessia and Picardo, Mauro and Ambrosio, Luca and Zalaudek, Iris and Pellacani, Giovanni and Conforti, Claudio},
title = {Artificial Intelligence‐Based Assessment With Line‐Field Confocal Optical Coherence Tomography ( LC ‐ OCT ) During Topical Ruxolitinib Therapy for Vitiligo},
journal = {International Journal of Dermatology},
year = {2026},
doi = {10.1111/ijd.70614}
}
EUVIMED